| Structure |
Chemical Name |
CAS |
MF |
 |
Isavuconazole Impurity 27 |
|
|
|
|
Istradefylline Impurity E |
|
|
|
|
Linagliptin Impurity 41 |
|
|
|
|
PalBociclib Impurity 17 |
|
|
|
|
PalBociclib Impurity 24 |
|
|
|
|
Posaconazole Impurity 12 |
|
|
 |
Posaconazole Impurity 24 |
165115-78-6 |
C19H20F2O2 |
 |
Sitagliptin Impurity 24 |
2349567-54-8 |
C15H19F2NO4 |
 |
Tamoxifen EP Impurity H |
809285-09-4 |
C43H48N2O2 |
|
|
Tenofovir impurity Q |
|
|
 |
Trelagliptin Impurity 20 |
1821520-42-6 |
C20H22FN5O3 |
 |
Umeclidinium Impurity 3 |
869113-45-1 |
C29H32BrNO3 |
 |
Vardenafil Impurity 7 |
448184-56-3 |
C21H26N6O7S |
 |
Moxifloxacin Related Compound A (HCl salt form) |
151282-23-4 |
C20H22ClF2N3O3 |
 |
8-Hydroxy Entecavir |
1795791-10-4 |
C12H15N5O4 |
![1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)-](/CAS/20180527/GIF/1404559-22-3.gif) |
1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)- |
1404559-22-3 |
C27H38N6O3S |
|
|
Ampicillin Impurity A |
|
|
|
|
Oxacillin Sodium Impurity B(EP) |
|
|
 |
3,5-dichlorothiophene-2-carboxylic acid |
89166-94-9 |
C5H2Cl2O2S |
 |
Brexpiprazole Impurity 2 |
2094559-58-5 |
C38H40N4O4S |
![2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid](/CAS/20180527/GIF/80047-38-7.gif) |
2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid |
80047-38-7 |
C12H10N2O3 |
 |
Levofloxacin Impurity 7 |
1607796-83-7 |
C15H14FNO5 |
|
|
Moxifloxacin EP Impurity E HCl |
|
|
 |
Pantoprazole Impurity 11 |
172282-50-7 |
C7H8F2N2O |
 |
Solifenacin Related Compound 24 |
1682642-69-8 |
C15H23ClN2 |
 |
Ticagrelor Related Compound 44 |
1431867-40-1 |
C8H12ClN3OS |
 |
(trans)-2-(3,4-difluorophenyl)cyclopropanecarboxamide |
1006614-51-2 |
C10H9F2NO |
 |
2-cyano-N-methyl-N-((3R,4R)-4-methyl piperidin-3-yl) Acetamide hydrochloride |
1640971-87-4 |
C10H18ClN3O |
 |
6-methyl-N1-(4-methyl-6-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine |
|
C17H17N5 |
 |
WPDCFRNNHUYQGW-IUXPMGMMSA-N |
1628639-06-4 |
C21H23NO4 |
 |
tert-Butyl 2-((4S,6S)-6-(chloromethyl(02,2-1,3-dioxan-4-yl)acetate |
521974-00-5 |
C13H23ClO4 |
 |
Cefadroxil Sulfoxide |
182290-77-3 |
C16H17N3O6S |
 |
GSFIWDGFHNAUFU-UHFFFAOYSA-N |
2125702-80-7 |
C16H29N5O4 |
 |
2,5-dichloro-N,N-dimethylbenzamide |
90526-01-5 |
C9H9Cl2NO |
 |
Ibrutinib Impurity 9 |
2068022-09-1 |
C25H21D5N6O4 |
 |
4-クロロ-3-ヒドロキシブチロニトリル |
105-33-9 |
C4H6ClNO |
 |
(Z)-2-propylhept-2-enal |
95667-14-4 |
C10H18O |
 |
(R)-3-AMINO-4-(2,4-DIFLUOROPHENYL)-BUTYRIC ACID-HCL |
1335470-16-0 |
C10H11F2NO2 |
 |
4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl |
2176485-21-3 |
C30H28Cl2O2 |
 |
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide |
294852-91-8 |
C18H22N2O |
![N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine](/CAS/20180629/GIF/1052691-22-1.gif) |
N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine |
1052691-22-1 |
C10H19N3S |
 |
3-pentylisoindolin-1-one |
691863-84-0 |
C13H17NO |
![(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate](/CAS/20180629/GIF/1598416-05-7.gif) |
(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate |
1598416-05-7 |
C22H20N2O5 |
 |
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N- ((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl) methyl)-N-methylmethanamine hydrochloride |
|
C33H28ClF2N5O4S2 |
 |
Labetalol EP impurity D |
32780-65-7 |
C9H13ClN2O3 |
![ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate](/CAS/20180702/GIF/625115-53-9.gif) |
ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate |
625115-53-9 |
C21H21FN8O2 |
|
|
Empagliflozin Impurity 34 |
|
|
 |
Sugammadex Impurity 22 |
2412952-94-2 |
C72H113NaO48S8 |
 |
Febuxostat |
1312815-36-3 |
C20H25NO4S |
 |
Itraconazole Impurity 34 |
103661-14-9 |
C14H15Cl2N3O5S |
 |
Lansoprazole Impurity 34 |
1357726-93-2 |
C7H8N2O3 |
 |
Meloxicam Impurity 1 HCl |
929568-25-2 |
C4H7ClN2O |
 |
Palonosetron Impurity 11 |
2216753-67-0 |
C18H24N2O |
|
|
Vonoprazan Impurity 4 |
|
|
|
|
Cinacalcet impurity K |
|
|
 |
Valsartan Impurity 13 |
|
C24H29N5O3 |
 |
Valsartan Impurity 27 |
|
C24H29N5O3 |
|
|
Etoricoxib Impurity 6 |
|
|
|
|
Ezetimibe impurity 3 |
|
|
 |
bis(1-benzylpiperidin-3-yl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
166808-97-5 |
C16H16N2O6 |
 |
Ticagrelor Imp.J |
2248538-63-6 |
C14H20ClN5O4S |
 |
Vortioxetine Imp.E |
508233-77-0 |
C18H22N2S |
 |
(3R,4S)-1-(4-fluorophenyl)-3-((S)-3-hydroxy-3-(p-tolyl)propyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-07-6 |
C25H24FNO3 |
|
|
Topiroxostat Impurity 1 |
|
|
|
|
Oxcarbazepine Impurity3 |
|
|
|
|
Mosapride IMP |
|
|
 |
4-Ethoxy Paroxetine |
606968-04-1 |
C21H25NO4 |
 |
Methylene-Bis Paroxetine |
1292846-10-6 |
C39H40F2N2O6 |
 |
Trelagliptin Impurity X |
1938080-44-4 |
C18H22FN5O3 |
|
|
Cefoxitin Sodium impurity |
|
|
![2-{[(methoxycarbonylmethyl)(toluene-4-sulfonyl)amino]methyl}-4-phenoxybenzoic acid methyl ester](/CAS/20180703/GIF/1455091-06-1.gif) |
2-{[(methoxycarbonylmethyl)(toluene-4-sulfonyl)amino]methyl}-4-phenoxybenzoic acid methyl ester |
1455091-06-1 |
C25H25NO7S |
 |
(1R,3S)-(3-Aminocyclopentyl) methanol |
117957-62-7 |
C6H13NO |
|
|
Canagliflozin Impurity 12 |
|
|
|
|
Canagliflozin Impurity G |
|
|
|
|
Dolutegravir Impurity 1 |
|
|
|
|
Empagliflozin impurity F |
|
|
|
|
Ibrutinib Impurity 12 |
|
|
 |
Nintedanib impurity J |
1139457-10-5 |
C23H17N3O5 |
 |
DSKNHVUKATXSCQ-GDVCOKDOSA-N |
188915-50-6 |
C14H14ClN3O4S |
 |
Clarthromycin EP Impurity B |
299409-85-1 |
C37H67NO13 |
 |
(4-Chloro-3-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester |
352277-93-1 |
C12H13ClF3NO2 |
![(1R,2S,5S)-2-アジド-5-[(ジメチルアミノ)カルボニル]シクロヘキシルカルバミン酸=tert-ブチル](/CAS/20180906/GIF/480450-69-9.gif) |
(1R,2S,5S)-2-アジド-5-[(ジメチルアミノ)カルボニル]シクロヘキシルカルバミン酸=tert-ブチル |
480450-69-9 |
C14H25N5O3 |
|
|
Rivaroxaban Impurity 24 |
|
|
 |
Ticagrelor |
1265919-24-1 |
C12H21NO5 |
 |
Clindamycin (2R-cis)-Diastereomer |
1440605-46-8 |
C18H33ClN2O5S |
|
|
Cabozantinib Impurity F |
|
|
 |
Cefmetazole sodium Impurity 7 |
60638-57-5 |
C11H14N6O4S2 |
|
|
Tadalafil EP Impurity I |
|
|
 |
1,4'-Bipiperidine, 1'-(phenylmethyl)- |
116269-53-5 |
C17H26N2 |
![[2-(4-Methoxyphenyl)-1-methylethyl]-formamide](/CAS/20180601/GIF/126002-14-0.gif) |
[2-(4-Methoxyphenyl)-1-methylethyl]-formamide |
126002-14-0 |
C11H15NO2 |
 |
Benzene, 1-chloro-2-(dimethoxymethyl)- |
70380-66-4 |
C9H11ClO2 |
![(R)-1-chloro-3-{[(4-chlorophenyl)methylene]amino}propan-2-ol](/CAS/20180601/GIF/1450915-93-1.gif) |
(R)-1-chloro-3-{[(4-chlorophenyl)methylene]amino}propan-2-ol |
1450915-93-1 |
C10H11Cl2NO |
![3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one](/CAS/20180601/GIF/877402-45-4.gif) |
3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one |
877402-45-4 |
C6H5F3N4O |
 |
4-((5,6-dimethoxy-1H-inden-2-yl)methyl)piperidine |
1026443-48-0 |
C17H23NO2 |
 |
Celecoxib Impurity |
170570-09-9 |
C18H16F3N3O2S |
 |
Indacaterol Impurity 7 |
1403389-05-8 |
C24H30N2O3 |
![tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate](/CAS/20180601/GIF/1883672-48-7.gif) |
tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
1883672-48-7 |
C29H38ClN7O4 |
 |
1-cyclopropyl-7-fluoro-6,8-dimethoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
C15H14FNO5 |
 |
cis-cyclo(Pro-Pro) |
19943-27-2 |
C10H14N2O2 |
 |
Ropivacaine-cycle |
1945965-95-6 |
C17H24N2O |